Intuitive Surgical Stock Intrinsic Value – Intuitive Surgical Stock Soars Above Market on Bullish Trading Day

December 14, 2023

🌥️Trending News

On a bullish trading day, Intuitive Surgical ($NASDAQ:ISRG) Inc.’s stock soared above the market, showing superior performance. Intuitive Surgical Inc. is a leading medical technology company focused on revolutionizing minimally invasive surgery by developing, manufacturing, and marketing robotic-assisted surgical systems. Their products are designed to improve access to surgical care, reduce recovery time, and improve patient outcomes. This strong performance has continued to attract investors to the company as they look for ways to capitalize on its success.

Intuitive Surgical Inc. is set to continue to be one of the top performers in the healthcare industry as it continues to develop and improve its products and services. With its current upward trajectory in the stock market, Intuitive Surgical Inc. looks set to remain a strong contender in the medical technology field for years to come.

Price History

Intuitive Surgical Inc. (ISI) stock had a great day on Wednesday, closing at $329.0 – up by 2.6% from the previous day’s closing price of $320.7. This marked an impressive rally over the bearish market trends for the day, as ISI was one of the few stocks that saw an increase in value, making it one of the main winners of the day. Opening at $320.7, the stock’s strong performance reflects investors’ confidence in the company’s prospects and is likely to further encourage an optimistic outlook in the upcoming days. Live Quote…

About the Company

  • Industry Classification
  • Key Executives
  • Ownership (Institutional/ Fund Holdings)
  • News Feed
  • Income Snapshot

    Below shows the total revenue, net income and net margin for Intuitive Surgical. More…

    Total Revenues Net Income Net Margin
    6.85k 1.52k 22.1%
  • Income Statement Reports (Yearly/ Quarterly/ LTM)
  • Income Supplement
  • Growth Performance
  • Cash Flow Snapshot

    Below shows the cash from operations, investing and financing for Intuitive Surgical. More…

    Operations Investing Financing
    2.02k 1.26k -1.22k
  • Cash Flow Statement (Yearly/ Quarterly/ LTM)
  • Cash Flow Supplement
  • Balance Sheet Snapshot

    Below shows the total assets, liabilities and book value per share for Intuitive Surgical. More…

    Total Assets Total Liabilities Book Value Per Share
    14.71k 2.09k 35.61
  • Balance Sheet (Yearly/ Quarterly)
  • Balance Sheet Supplement
  • Key Ratios Snapshot

    Some of the financial key ratios for Intuitive Surgical are shown below. More…

    3Y Rev Growth 3Y Operating Profit Growth Operating Margin
    16.7% 17.9% 24.7%
    FCF Margin ROE ROA
    18.3% 8.6% 7.2%
  • Income Statement Ratios
  • Balance Sheet Ratios
  • Cash Flow Ratios
  • Valuation Ratios
  • Other Ratios
  • Other Supplementary Items
  • Analysis – Intuitive Surgical Stock Intrinsic Value

    At GoodWhale, we believe in taking a thorough and detailed approach to analyzing a stock’s fundamentals. That’s why we are proud to present our analysis of INTUITIVE SURGICAL. Our proprietary Valuation Line has calculated the fair value of INTUITIVE SURGICAL shares to be around $326.1. This means that INTUITIVE SURGICAL is currently being traded at $329.0, a fair price that is close to the fair value. We believe that this makes it an attractive investment for those looking to add INTUITIVE SURGICAL to their portfolio. More…

  • Star Chart Analysis
  • Valuation Analysis




  • Peers

    The company’s da Vinci surgical system consists of a surgeon’s console, a patient-side cart and a vision system. The company’s competitors in the robotic surgery market include Stryker Corp, Medtronic PLC, Becton, Dickinson and Co.

    – Stryker Corp ($NYSE:SYK)

    With a market capitalization of $84.98 billion as of 2022, Stryker Corporation is one of the world’s leading medical technology companies. Headquartered in Kalamazoo, Michigan, the company offers a broad range of products and services in orthopedics, medical and surgical, and neurotechnology and spine that help improve patient care and quality of life. The company’s products include implants used in hip, knee and shoulder replacements, as well as instrumentation and software used in operating rooms and for patient rehabilitation. In addition, Stryker offers a wide range of products and services for minimally invasive surgery, including robotic-assisted surgery systems. The company’s return on equity was 10.79% as of 2022.

    – Medtronic PLC ($NYSE:MDT)

    Medtronic PLC is a medical technology company that develops and produces a variety of medical devices and software products. The company has a market capitalization of 112.31 billion as of 2022 and a return on equity of 7.49%. Medtronic PLC’s products are used in a wide range of medical procedures, including cardiovascular, neurological, and orthopedic procedures. The company’s products are sold in over 150 countries around the world.

    – Becton, Dickinson and Co ($NYSE:BDX)

    Becton, Dickinson and Co is a medical technology company that manufactures and sells medical devices, laboratory equipment, and diagnostic products. The company has a market cap of 64.37B as of 2022 and a return on equity of 6.42%. The company’s products are used in a variety of medical procedures, including blood transfusions, IV start kits, and diabetes care.

    Summary

    Intuitive Surgical Inc. (INTU) stock rose significantly on a strong trading day, outperforming the market. Analysts attribute this to positive investor sentiment towards the company due to strong fundamentals and growing demand for its products. The company’s strong balance sheet and steady cash flow have enabled it to expand its operations, invest in research and development, and return capital to shareholders through dividends and share repurchasing.

    INTU also boasts a market-leading product portfolio with high profit margins, and an experienced management team that has demonstrated an ability to execute on decisions and drive value. With increasing demand for its products and a promising outlook for the future, INTU remains an attractive option for investors.

    Recent Posts

    Leave a Comment